Microbiology :: Tips from the Journals of the American Society for Microbiology

The following articles are featured in the upcoming issue of the Journals of the American Society for Microbiology: Novel H3N1 swine influenza virus identified in pigs in Korea; New treatment using human antibodies to target harmful toxins may protect against C. cifficile; and Guinea pig aerosol challenge presents new model for Q fever research in humans.

SARS :: Setting the stage to find drugs against SARS

Scientists at the U.S. Department of Energy’s Brookhaven National Laboratory have set the stage for the rapid identification of compounds to fight against severe acquired respiratory syndrome (SARS), the atypical pneumonia responsible for about 800 deaths worldwide since first recognized in late 2002.

HIV :: Massachusetts To Record HIV Patients’ Names

AIDS Action Committee of Massachusetts, Inc. today announced its opposition to the Public Health Council’s adoption of a regulation requiring providers to report cases of HIV infection by name to the Department of Public Health, instead of the code that has been in use since 1999.

Immunity :: New light shed on immune system development

Research led by King’s scientists, and published online in the journal Nature, sheds new light on the development of the immune cells which are critical in fighting infection and some tumours. It may also provide clues to the mystery of why autoimmune diseases in women often go into remission during pregnancy.

Flu :: CDC Announces Weeklong Event to Focus on the Importance of Influenza Vaccination

The Centers for Disease Control and Prevention (CDC) today announced the designation of the week after Thanksgiving as National Influenza Vaccination Week. This year, National Influenza Vaccination Week will run from November 27 to December 3. This event is designed to raise awareness of the importance of continuing influenza (flu) vaccination, as well as foster greater use of flu vaccine through the months of November, December and beyond.

Newly identified strains of Chlamydia trachomatis could produce new diseases

A new study led by a scientist at Children’s Hospital Oakland Research Institute (CHORI) is the first to conclude that Chlamydia trachomatis is evolving at a rate faster than scientists first thought or imagined. Chlamydia trachomatis is a bacterium that is the leading cause of sexually transmitted diseases and the second leading cause of blindness worldwide.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack